A microarray analysis comprising 40,000 cDNA gene chip arrays conducted by Sridhar et al. 13 identified 11 differentially expressed genes between CD34+ BM cells from tMDS (patients whose MDS transformed to AML) and sMDS (patients who remained stable). The gene discussed is CD34; the disease is myelodysplastic syndrome.